Amicus Therapeutics Inc. buy Guggenheim
Start price
07.11.24
/
50%
€10.20
Target price
07.11.25
€13.91
Performance (%)
-25.49%
End price
08.11.25
€7.60
Summary
This prediction ended on 08.11.25 with a price of €7.60. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -25.49%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Guggenheim for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at Guggenheim from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten